ARCA Biopharma Inc (NASDAQ:ABIO)
| 0.5323 Delayed Data As of Apr 26 |  +0.0106 / +2.03%Today’s Change | 0.45 Today|||52-Week Range 2.76 | -60.57% Year-to-Date |
Latest ABIO News | Press Releases
No recent news for ARCA Biopharma Inc.
Today’s Trading
| Previous close | 0.52 |
| Today’s open | 0.52 |
| Day’s range | 0.52 - 0.57 |
| Volume | 126,572 |
| Average volume (3 months) | 846,364 |
| Market cap | $7.6M |
Data as of 3:59pm ET, 04/26/2018
Growth & Valuation
| Earnings growth (last year) | +0.55% |
| Earnings growth (this year) | -7.73% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OGENOragenics Inc | -0.08 | -5.44% |
| ANTHAnthera Pharmaceutic... | -0.01 | -1.64% |
| CBIOCatalyst Biosciences... | +1.12 | +4.18% |
| KZIAKazia Therapeutics L... | +0.05 | +0.92% |
Data as of 8:00pm ET, 04/26/2018
Financials
| Next reporting date | May 9, 2018 |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$16.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow |
Chief Operating Officer Thomas A. Keuer |
Corporate headquarters Westminster, Colorado |
Forecasts
